Find Liporeduct Forte manufacturers, exporters & distributors on PharmaCompass

PharmaCompass

Synopsis

Synopsis

ACTIVE PHARMA INGREDIENTS

0

API Suppliers

API Suppliers

0

USDMF

US DMFs Filed

0

CEP/COS

CEP/COS Certifications

0

JDMF

JDMFs Filed

0

EU WC

EU WC

0

KDMF

KDMF

0

NDC API

NDC API

0

VMF

NDC API

0

Listed Suppliers

Other Suppliers

API REF. PRICE (USD/KG)

$
$ 0

MARKET PLACE

0

API

0

FDF

0INTERMEDIATES

FINISHED DOSAGE FORMULATIONS

0

FDF Dossiers

FDF Dossiers

0

FDA Orange Book

FDA (Orange Book)

0

Europe

Europe

0

Canada

Canada

0

Australia

Australia

0

South Africa

South Africa

0

Listed Dossiers

Listed Dossiers

0 DRUGS IN DEVELOPMENT

FDF Dossiers

DRUG PRODUCT COMPOSITIONS

REF. STANDARDS OR IMPURITIES

0

EDQM

0

USP

0

JP

0

Others

PATENTS & EXCLUSIVITIES

0

US Patents

0

US Exclusivities

0

Health Canada Patents

DIGITAL CONTENT

0

Data Compilation #PharmaFlow

0

Stock Recap #PipelineProspector

0

Weekly News Recap #Phispers

0

News #PharmaBuzz

GLOBAL SALES INFORMATION

US Medicaid

NA

Annual Reports

NA

Finished Drug Prices

NA

0RELATED EXCIPIENT COMPANIES

0EXCIPIENTS BY APPLICATIONS

Chemistry

Click the arrow to open the dropdown
read-moreClick the button for full data set
Also known as: 57456-45-8, 2-(4-chlorophenoxy)-2-methylpropanoic acid;[2,3,4,5,6-pentakis(pyridine-3-carbonyloxy)cyclohexyl] pyridine-3-carboxylate, Clofibrate - inositol hexanicotinate mixture, Inositol hexanicotinate - clofibrate mixture, Clofibrate mixture with inositol hexanicotinate, Clofibrate - inositol nicotinate
Molecular Formula
C52H41ClN6O15
Molecular Weight
1025.4  g/mol
InChI Key
GMZMSRVZQKDYFL-UHFFFAOYSA-N

Liporeduct Forte
1 2D Structure

Liporeduct Forte

2 Identification
2.1 Computed Descriptors
2.1.1 IUPAC Name
2-(4-chlorophenoxy)-2-methylpropanoic acid;[2,3,4,5,6-pentakis(pyridine-3-carbonyloxy)cyclohexyl] pyridine-3-carboxylate
2.1.2 InChI
InChI=1S/C42H30N6O12.C10H11ClO3/c49-37(25-7-1-13-43-19-25)55-31-32(56-38(50)26-8-2-14-44-20-26)34(58-40(52)28-10-4-16-46-22-28)36(60-42(54)30-12-6-18-48-24-30)35(59-41(53)29-11-5-17-47-23-29)33(31)57-39(51)27-9-3-15-45-21-27;1-10(2,9(12)13)14-8-5-3-7(11)4-6-8/h1-24,31-36H;3-6H,1-2H3,(H,12,13)
2.1.3 InChI Key
GMZMSRVZQKDYFL-UHFFFAOYSA-N
2.1.4 Canonical SMILES
CC(C)(C(=O)O)OC1=CC=C(C=C1)Cl.C1=CC(=CN=C1)C(=O)OC2C(C(C(C(C2OC(=O)C3=CN=CC=C3)OC(=O)C4=CN=CC=C4)OC(=O)C5=CN=CC=C5)OC(=O)C6=CN=CC=C6)OC(=O)C7=CN=CC=C7
2.2 Synonyms
2.2.1 MeSH Synonyms

1. Clofibrate - Inositol Nicotinate

2. Clofibrate, Inositol Nicotinate Drug Combination

3. Liporeduct

2.2.2 Depositor-Supplied Synonyms

1. 57456-45-8

2. 2-(4-chlorophenoxy)-2-methylpropanoic Acid;[2,3,4,5,6-pentakis(pyridine-3-carbonyloxy)cyclohexyl] Pyridine-3-carboxylate

3. Clofibrate - Inositol Hexanicotinate Mixture

4. Inositol Hexanicotinate - Clofibrate Mixture

5. Clofibrate Mixture With Inositol Hexanicotinate

6. Clofibrate - Inositol Nicotinate

7. Clofibrate, Inositol Nicotinate Drug Combination

8. Myo-inositol, Hexa-3-pyridinecarboxylate, Mixt. With 2-(4-chlorophenoxy)-2-methylpropanoic Acid

2.3 Create Date
2007-01-09
3 Chemical and Physical Properties
Molecular Weight 1025.4 g/mol
Molecular Formula C52H41ClN6O15
Hydrogen Bond Donor Count1
Hydrogen Bond Acceptor Count21
Rotatable Bond Count21
Exact Mass1024.2318423 g/mol
Monoisotopic Mass1024.2318423 g/mol
Topological Polar Surface Area282 Ų
Heavy Atom Count74
Formal Charge0
Complexity1420
Isotope Atom Count0
Defined Atom Stereocenter Count0
Undefined Atom Stereocenter Count0
Defined Bond Stereocenter Count0
Undefined Bond Stereocenter Count0
Covalently Bonded Unit Count2

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty